Parkinson's Disease

Below is a general introduction from the NIH on Parkinson's Disease. It also has excellent resources on other literature to review.

What is Parkinson's Disease?
Parkinson's disease (PD) belongs to a group of conditions called motor system disorders, which are the result of the loss of dopamine-producing brain cells. The four primary symptoms of PD are tremor, or trembling in hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia, or slowness of movement; and postural instability, or impaired balance and coordination. As these symptoms become more pronounced, patients may have difficulty walking, talking, or completing other simple tasks. PD usually affects people over the age of 50. Early symptoms of PD are subtle and occur gradually. In some people the disease progresses more quickly than in others. As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately. Doctors may sometimes request brain scans or laboratory tests in order to rule out other diseases.

Parkinson disease is a brain disorder related to the death or impairment of the brain cells that produce dopamine.

When approximately 80% of the dopamine-producing cells are damaged, the symptoms of Parkinson disease appear.

On July 19th 2006, President Bush issued the first veto of his five-year-old administration, rejecting Congress' attempt to lift funding restrictions on embryonic stem-cell research.

Even though both the Republican-controlled House and Senate passed the stem-cell legislation by comfortable margins, they did not have the two-thirds majority required to override the veto.

Brussels has announced stricter and streamlined rules for the approval of pesticides for use in EU agriculture.

The European commission, on Wednesday, July 12, 2006, set out plans to ensure safer use of pesticides and to reduce red tape in authorisation procedures of plant protection products.